ESC Action Center
Welcome to the ESC Action Center, where you’ll find breaking news and insights from the European Society of Cardiology (ESC) Congress. Explore pivotal presentations, innovative research findings, and emerging treatments to stay at the forefront of the latest advancements in cardiology.
1-9 of 9
Subcutaneous Lp(a)-Lowering Therapies: Understanding the Evidence
Heart MattersSubcutaneous Lp(a)-Lowering Therapies: Understanding the Evidence
M. Melih Dogan, MD
Reducing Cardiovascular Risk in Adult Survivors of Childhood Cancer
Heart MattersReducing Cardiovascular Risk in Adult Survivors of Childhood Cancer
Stephanie Dixon, MD, MPH
Adapting CV Risk Reduction Strategies for Cancer Survivorship
Heart MattersAdapting CV Risk Reduction Strategies for Cancer Survivorship
Stephanie Dixon, MD, MPH
A Long-Term View of Cardiovascular Risk After Cancer Treatment
Heart MattersA Long-Term View of Cardiovascular Risk After Cancer Treatment
Stephanie Dixon, MD, MPH
APOC3 Inhibition in FCS and Severe Hypertriglyceridemia
CardiologyAPOC3 Inhibition in FCS and Severe Hypertriglyceridemia
Erik Stroes
Bruno Batinica, MD
- advertisement
Advancing ATTR-CM Identification: Early Findings from TRACE-AI
Heart MattersAdvancing ATTR-CM Identification: Early Findings from TRACE-AI
Bruno Batinica, MD
Plozasiran for Severe Hypertriglyceridemia: 12-Month Results From the SHASTA-3 and SHASTA-4 Trials at ESC
CardiologyPlozasiran for Severe Hypertriglyceridemia: 12-Month Results From the SHASTA-3 and SHASTA-4 Trials at ESC
Prof. dr. Gerald Watts
A More Complete View of Cardiovascular Risk in Women
Heart MattersA More Complete View of Cardiovascular Risk in Women
Noel Bairey Merz, MD
